Finally, a set of cancer-associated and immune-related pathways and biological functions were enriched in Cluster2, such as cell adhesion molecules, focal adhesion, MET activates PTK2 signaling and leukocyte transendothelial migration, indicating that patients in Cluster2 may be more likely to metastasis and immune response. Here, MET is linked to cancer.